Simple nerve stimulation may improve sexual response in women
(Michigan Medicine - University of Michigan) Electrodes aren't the first thing most people think of when it comes to achieving sexual arousal. But if the results of a pilot study are any indication, that may soon change. Michigan Medicine researchers find that a treatment typically used for overactive bladder may also be effective for female sexual dysfunction. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 5, 2018 Category: International Medicine & Public Health Source Type: news
BlueWind posts positive follow-up study results
BlueWind Medical’s implantable tibial stimulation device
Neurostim developer BlueWind Medical reported positive results from a follow-up study of patients using its implantable tibial nerve stimulator for overactive bladder (OAB).
Renova iStim is a leadless, miniature, wireless neurostimulation platform designed for the treatment of multiple clinical indications. Three years after implantation of the BlueWind’s Renova iStim device, 75% of patients experienced at least a 50% long-term reduction in symptoms. Patients experienced a durable, long-term, effect of urinary urge incontinence relief in “leaks” (50% of pa...
Source: Mass Device - August 31, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Food & Drug Administration (FDA) Implants Neuromodulation/Neurostimulation Research & Development Urology Bluewind Medical Source Type: news
Nuvectra Suffers Painful Stock Drop After Regulatory Update
A company that spun out of Greatbatch in 2016 experienced a painful drop in its stock price Monday after updating investors on its regulatory progress for a sacral neuromodulation (SNM) system designed to treat chronic urinary retention and the symptoms of overactive bladder.
Plano, TX-based Nuvectra said FDA has asked for additional information related to any modifications or changes to its Virtis device, labeling, and manufacturing as well as clarifications of data related to MRI. The company also has been asked to submit clinical study data to the European Union regulatory before it can recommend CE mark approval for...
Source: MDDI - July 3, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
18 years old and still wetting the bed: Teenager speaks out about his lifelong bladder problem
Seb Cheer, 18, from Cardiff, has suffered with an overactive bladder for his whole life but, now at Leeds University, he is encouraging other young people to discuss the condition. (Source: the Mail online | Health)
Source: the Mail online | Health - June 29, 2018 Category: Consumer Health News Source Type: news
BlueWind Medical Receives FDA Approval for Pivotal Trial Design of RENOVA iStim(TM) Implantable Tibial Nerve Neuromodulator for Overactive Bladder
HERZLIYA, Israel, June 14, 2018 -- (Healthcare Sales & Marketing Network) -- BlueWind Medical, a developer of a miniature wireless neurostimulation platform, for the treatment of multiple clinical indications, announced today that the US Food and Drug Adm... Devices, Urology, Neurology, FDA BlueWind Medical, RENOVA iStim, overactive bladder, Tibial Stimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2018 Category: Pharmaceuticals Source Type: news
Medical News Today: Foods for bladder health
Having an overactive bladder can be a very challenging condition, but there are many ways in which people can improve their symptoms. These include monitoring the foods and drinks that they consume, as well as avoiding alcohol, caffeine, and spicy foods. Learn more about the overactive bladder diet here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 18, 2018 Category: Consumer Health News Tags: Overactive Bladder (OAB) Source Type: news
Neuromodulation Continues to be Activity Hotbed
The Neuromodulation market is rapidly growing and has become host to many medtech companies. StimGuard is the latest firm to make significant moves in the space, as it has received CE mark for a wireless neuromodulation device to treat chronic symptoms of overactive bladder.
The Pompano Beach, Fla.-based company said its StimGuard would be available in Europe in the summer of 2018.
“A wireless system that enables urologists to inject such a clinically proven therapy represents a shift in the field where there has only been one option for over 15 years,” Karl-Dietrich Sievert MD, PhD, professor and co-chairman of urolog...
Source: MDDI - May 18, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news
StimGuard wins CE Mark for SNS overactive bladder treatment
StimGuard said today it won CE Mark approval in the European Union for its sacral nerve stimulator designed to treat intractable symptoms of overactive bladder, with plans to launch the device in the EU this summer.
The Pompany Beach, Fla.-based company touted that the StimGuard SNS system can be implanted through a needle without a surgery, as the device is 95% smaller than other similar sacral nerve stimulation devices on the market. The system uses an Apple iPad as a programming console, the company added.
“A wireless system that enables urologists to inject such a clinically proven therapy represents a shift in ...
Source: Mass Device - May 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Neuromodulation/Neurostimulation Regulatory/Compliance StimGuard Source Type: news
FDA Approves Mirabegron, Solifenacin Combo for OAB FDA Approves Mirabegron, Solifenacin Combo for OAB
The FDA has approved mirabegron (Myrbetriq, Astellas Pharma) in combination with solifenacin succinate for the treatment of overactive bladder (OAB).FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 9, 2018 Category: Consumer Health News Tags: Urology News Alert Source Type: news
FDA Approves Supplemental New Drug Application for Myrbetriq (mirabegron) for Use in Combination with Solifenacin Succinate for the Treatment of Overactive Bladder Symptoms
TOKYO, May 7, 2018 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., " Astellas " ) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 7, 2018 Category: Drugs & Pharmacology Source Type: news
Urovant Sciences Strengthens Executive Management Team with Senior Hires and Establishes U.S. Headquarters in Irvine, California
Cornelia Haag-Molkenteller, former VP and Therapeutic Area Head, Clinical Development, for Urology, Women's Health, and Internal Medicine at Allergan, joins as Chief Medical Officer
Michael McFadden, former SVP for Commercial at Avanir, joins as Chief C... Biopharmaceuticals, Urology, Personnel Urovant Sciences, Vibegron, overactive bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news
Laborie Medical closes $214m Cogentix buy
Laborie Medical Technologies said today that it closed the $214 million acquisition of Cogentix Medical (NSDQ:CGNT).
With about 85% of the urology and gynecology device maker’s shares tendered over the weekend, meeting the minimum tender requirement, the stage was set for the deal to close today. The $3.85-per-share cash tender pulled in some 51.5 million shares, for about $198.2 million, Laborie said April 21.
The deal represents a 14.2% premium over CGNT stock’s $3.37 closing price March 9, the last business day before the deal was announced.
“Our combined, complementary product portfolio provides our...
Source: Mass Device - April 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Urology Women's Health Cogentix Medical Laborie Medical Technologies Source Type: news
Medical News Today: How many times a day should a person pee?
A person will usually urinate more frequently at certain times of day and when they are well hydrated. However, some medical conditions cause a person to pee too often or not often enough. Pregnancy and advancing age can also play a role. Here, learn what causes irregular or frequent urination and how to manage it. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 11, 2018 Category: Consumer Health News Tags: Overactive Bladder (OAB) Source Type: news
Medical News Today: Is it safe to hold your pee? Five possible complications
It is usually best to go to the bathroom when the urge hits, but sometimes life gets in the way. Here, learn about the possible complications of holding in pee, including urinary tract infections, damaged pelvic floor muscles, cramping, kidney stones, and more. We also discuss tips for reaching a toilet in time. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 5, 2018 Category: Consumer Health News Tags: Overactive Bladder (OAB) Source Type: news
Medical News Today: What causes urine leakage while coughing?
Peeing while coughing is a form of stress incontinence. It can happen to men and women and is associated with physical activity, such as running or jumping, when pressure is put on the bladder and urine is released unintentionally. Learn about this condition here, including causes, management, and what to do. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 29, 2018 Category: Consumer Health News Tags: Overactive Bladder (OAB) Source Type: news
